Literature DB >> 29574911

Long noncoding RNAs in cancer-immunity cycle.

Wei-Di Yu1, Huanhuan Wang2, Qi-Feng He1, Yong Xu3, Xiao-Chen Wang1.   

Abstract

The imbalance of immune status in cancer microenvironment plays an important role in the development and progression of cancer. Immunotherapy based on this has become an important field of cancer research in recent years. Many studies on long noncoding RNA (lncRNA) in cancer have focus on its regulation in cancer development and metastasis. Recent studies have suggested that lncRNAs play crucial roles in different phases of cancer immunity, including antigen releasing, antigen presentation, immune activation, immune cells migration, infiltrating into cancer tissues, and killing cancer cells. The functional studies of lncRNAs in cancer immuntity revealed the complicated molecular mechanisms in cancer immunity from a new point of view, which may provide novel potential targets for cancer immunotherapies. Based on the classical cancer-immunity cycle theory, we review the recent studies on the functions and mechanisms of immune-related lncRNAs in different stages of cancer immunity, to summarize the relationship between lncRNAs, and cancer immunity and to provide a framework for further research.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer; cancer-immunity cycle; immunity; lncRNA

Mesh:

Substances:

Year:  2018        PMID: 29574911     DOI: 10.1002/jcp.26568

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  52 in total

1.  Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma.

Authors:  Hao Feng; Xiaoqi Zhang; Wenli Lai; Jian Wang
Journal:  Cell Cycle       Date:  2020-05-25       Impact factor: 4.534

2.  Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.

Authors:  Xiangjun Qi; Guoming Chen; Zhuangzhong Chen; Jing Li; Wenmin Chen; Jietao Lin; Lizhu Lin
Journal:  Int J Gen Med       Date:  2021-08-11

3.  Construction and validation of an eight pyroptosis-related lncRNA risk model for breast cancer.

Authors:  Miduo Tan; Guo Huang; Jingjing Chen; Jiansheng Yi; Xi Liu; Ni Liao; Yi Hu; Wei Zhou; Qiong Guo
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

4.  Immune-Related LncRNAs as Prognostic Factors for Pediatric Rhabdoid Tumor of the Kidney.

Authors:  Ye Hong; Yi Que; Yang Hu; Bo-Yun Shi; Jia Zhu; Juan Wang; Jun-Ting Huang; Fei-Fei Sun; Lian Zhang; Xin-Ke Zhou; Su-Ying Lu; Yi-Zhuo Zhang
Journal:  Dis Markers       Date:  2022-06-15       Impact factor: 3.464

Review 5.  Long non-coding RNAs in brain tumors: roles and potential as therapeutic targets.

Authors:  Sung-Hyun Kim; Key-Hwan Lim; Sumin Yang; Jae-Yeol Joo
Journal:  J Hematol Oncol       Date:  2021-05-12       Impact factor: 17.388

6.  Integrated Characterization of lncRNA-Immune Interactions in Prostate Cancer.

Authors:  Wei Hu; Yanru Wang; Zhixiao Fang; Wei He; Shengli Li
Journal:  Front Cell Dev Biol       Date:  2021-02-16

7.  Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.

Authors:  Yuxuan Song; Donghui Jin; Jingyi Chen; Zhiwen Luo; Guangyuan Chen; Yongjiao Yang; Xiaoqiang Liu
Journal:  Aging (Albany NY)       Date:  2020-06-24       Impact factor: 5.682

8.  Pan-cancer characterization of lncRNA modifiers of immune microenvironment reveals clinically distinct de novo tumor subtypes.

Authors:  Zicheng Zhang; Congcong Yan; Ke Li; Siqi Bao; Lei Li; Lu Chen; Jingting Zhao; Jie Sun; Meng Zhou
Journal:  NPJ Genom Med       Date:  2021-06-17       Impact factor: 8.617

9.  Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.

Authors:  Ruonan Jiao; Wei Jiang; Xin Wei; Mengpei Zhang; Si Zhao; Guangming Huang
Journal:  BMC Cancer       Date:  2020-07-16       Impact factor: 4.430

10.  Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma.

Authors:  Pengcheng Zhou; Yuhua Lu; Yewei Zhang; Lei Wang
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.